$12.44-23.45% · 3M
Moving avg
1W+5.16%
1M+0.48%
3M-23.45%
6M-23.45%
YTD-23.45%
1Y-23.45%
3Y-23.45%
5Y-23.45%
52-week range
$10.5027% of range$17.80
Company health
Value0/6
Growth0/6
Profitability0/6
Health0/6
Dividend0/6
Key statistics
Valuation
Market cap
$3.50B
Enterprise value
$3.50B
P/E ratio (TTM)
-
P/S ratio (TTM)
-
EV/EBITDA
-
Per share & returns
EPS (TTM)
-
Dividend yield
-
Beta (1Y)
0.15
30-day change
+0.48%
Trading
Volume (24h)
471.6845
Previous close
$12.69
Shares outstanding
281.53M
About Vicore Pharma Holding AB
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
VCRE
Vicore Pharma Holding AB is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ under the ticker VCRE.
Frequently asked questions
What is Vicore Pharma Holding AB's market cap?
Vicore Pharma Holding AB (VCRE) has a market capitalization of $3.50B.
What sector is Vicore Pharma Holding AB in?
Vicore Pharma Holding AB operates in the Healthcare sector, Biotechnology industry.
What exchange does VCRE trade on?
VCRE trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,221.41+0.09%
$1.15T cap
Johnson & JohnsonJNJ
$261.39+0.20%
$629.92B cap
AbbVie Inc.ABBV
$250.64+0.76%
$442.83B cap
UnitedHealth Group IncorporatedUNH
$403.17-0.60%
$366.14B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap